This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481: 463–468.BoströmPWuJJedrychowskiMPKordeAYeLLoJCRasbachKABoströmEAChoiJHLongJZA PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis201248146346810.1038/nature10777352209822237023Search in Google Scholar
Kurdiova T, Balaz M, Mayer A, Maderova D, Belan V, Wolfrum C, Ukropec J, Ukropcova B. Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes. Peptides. 2014; 56: 1–7.KurdiovaTBalazMMayerAMaderovaDBelanVWolfrumCUkropecJUkropcovaBExercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes2014561710.1016/j.peptides.2014.03.00324642356Search in Google Scholar
Raschke S, Elsen M, Gassenhuber H, Sommerfeld M, Schwahn U, Brockmann B, Jung R, Wisløff U, Tjønna AE, Raastad T, et al. Evidence against a beneficial effect of irisin in humans. PLoS One, 2013; 8: e73680.RaschkeSElsenMGassenhuberHSommerfeldMSchwahnUBrockmannBJungRWisløffUTjønnaAERaastadTEvidence against a beneficial effect of irisin in humans20138e7368010.1371/journal.pone.0073680377067724040023Search in Google Scholar
Chen N, Li Q, Liu J, Jia S. Irisin, an exercise-induced myokine as a metabolic regulator: An updated narrative review. Diabetes Metab Res Rev. 2016; 32: 51–59.ChenNLiQLiuJJiaSIrisin, an exercise-induced myokine as a metabolic regulator: An updated narrative review201632515910.1002/dmrr.266025952527Search in Google Scholar
Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012; 61: 1725–1738.HuhJYPanagiotouGMougiosVBrinkoetterMVamviniMTSchneiderBEMantzorosCSFNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise2012611725173810.1016/j.metabol.2012.09.002361441723018146Search in Google Scholar
Aydin S, Kuloglu T, Aydin S, Kalayci M, Yilmaz M, Cakmak T, Albayrak S, Gungor S, Colakoglu N, Ozercan IH. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides. 2014; 61: 130–136.AydinSKulogluTAydinSKalayciMYilmazMCakmakTAlbayrakSGungorSColakogluNOzercanIHA comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues20146113013610.1016/j.peptides.2014.09.01425261800Search in Google Scholar
Aydin S, Aydin S, Kobat MA, Kalayci M, Eren MN, Yilmaz M, Kuloglu T, Gul E, Secen O, Alatas OD, Baydas A. Decreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology. Peptides. 2014; 56: 141–145.AydinSAydinSKobatMAKalayciMErenMNYilmazMKulogluTGulESecenOAlatasODBaydasADecreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology20145614114510.1016/j.peptides.2014.04.00224747283Search in Google Scholar
Piya MK, Harte AL, Sivakumar K, Tripathi G, Voyias PD, James S, Sabico S, Al-Daghri NM, Saravanan P, Barber TM, Kumar S, Vatish M, McTernan PG. The identification of irisin in human cerebrospinal fluid: Influence of adiposity, metabolic markers, and gestational diabetes. Am J Physiol Endocrinol Metab. 2014; 306: E512–E518.PiyaMKHarteALSivakumarKTripathiGVoyiasPDJamesSSabicoSAl-DaghriNMSaravananPBarberTMKumarSVatishMMcTernanPGThe identification of irisin in human cerebrospinal fluid: Influence of adiposity, metabolic markers, and gestational diabetes2014306E512E51810.1152/ajpendo.00308.201324398403Search in Google Scholar
Pinkowska A, Podhorska-Okołów M, Dzięgiel P, Nowińska K. The role of irisin in cancer disease. Cells. 2021; 10: 1479.PinkowskaAPodhorska-OkołówMDzięgielPNowińskaKThe role of irisin in cancer disease202110147910.3390/cells10061479823111734204674Search in Google Scholar
Kim H, Wrann CD, Jedrychowski M, Vidoni S, Kitase Y, Nagano K, Zhou C, Chou J, Parkman VA, Novick SJ, et al. Irisin mediates effects on bone and fat via αV integrin receptors. Cell. 2018; 175: 1756–1768.KimHWrannCDJedrychowskiMVidoniSKitaseYNaganoKZhouCChouJParkmanVANovickSJIrisin mediates effects on bone and fat via αV integrin receptors20181751756176810.1016/j.cell.2018.10.025629804030550785Search in Google Scholar
Oguri Y, Shinoda K, Kim H, Alba DL, Bolus WR, Wang Q, Brown Z, Pradhan RN, Tajima K, Yoneshiro T, et al. CD81 controls beige fat progenitor cell growth and energy balance via FAK signaling. Cell. 2020; 182: 563–577.OguriYShinodaKKimHAlbaDLBolusWRWangQBrownZPradhanRNTajimaKYoneshiroTCD81 controls beige fat progenitor cell growth and energy balance via FAK signaling202018256357710.1016/j.cell.2020.06.021741567732615086Search in Google Scholar
Bi J, Zhang J, Ren Y, Du Z, Li T, Wang T, Zhang L, Wang M, Wu Z, Lv Y, Wu R. Irisin reverses intestinal epithelial barrier dysfunction during intestinal injury via binding to the integrin αVβ5 receptor. J Cell Mol Med. 2020; 24: 996–1009.BiJZhangJRenYDuZLiTWangTZhangLWangMWuZLvYWuRIrisin reverses intestinal epithelial barrier dysfunction during intestinal injury via binding to the integrin αVβ5 receptor202024996100910.1111/jcmm.14811693338431701659Search in Google Scholar
Park EJ, Myint PK, Ito A, Appiah MG, Darkwah S, Kawamoto E, Shimaoka M. Integrin-ligand interactions in inflammation, cancer, and metabolic disease: Insights into the multifaceted roles of an emerging ligand irisin. Front Cell Dev Biol. 2020; 8: 588066.ParkEJMyintPKItoAAppiahMGDarkwahSKawamotoEShimaokaMIntegrin-ligand interactions in inflammation, cancer, and metabolic disease: Insights into the multifaceted roles of an emerging ligand irisin2020858806610.3389/fcell.2020.588066764975733195249Search in Google Scholar
Pukajło K, Kolackov K, Łaczmański Ł, Daroszewski J. Irisin – a new mediator of energy homeostasis. Postepy Hig Med Dosw. 2015; 69: 233–242.PukajłoKKolackovKŁaczmańskiŁDaroszewskiJIrisin – a new mediator of energy homeostasis20156923324210.5604/17322693.114109725720610Search in Google Scholar
Spiegelman BM. Banting Lecture 2012: Regulation of adipogenesis: Toward new therapeutics for metabolic disease. Diabetes. 2013; 62: 1774–1782.SpiegelmanBMBanting Lecture 2012: Regulation of adipogenesis: Toward new therapeutics for metabolic disease2013621774178210.2337/db12-1665366162123704518Search in Google Scholar
Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007; 293: E444–E552.NedergaardJBengtssonTCannonBUnexpected evidence for active brown adipose tissue in adult humans2007293E444E55210.1152/ajpendo.00691.200617473055Search in Google Scholar
van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P, Teule GJ. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009; 360: 1500–1508.van Marken LichtenbeltWDVanhommerigJWSmuldersNMDrossaertsJMKemerinkGJBouvyNDSchrauwenPTeuleGJCold-activated brown adipose tissue in healthy men20093601500150810.1056/NEJMoa080871819357405Search in Google Scholar
Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Nedergaard J. Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem. 2010; 285: 7153–7164.PetrovicNWaldenTBShabalinaIGTimmonsJACannonBNedergaardJChronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes20102857153716410.1074/jbc.M109.053942284416520028987Search in Google Scholar
Chen JQ, Huang YY, Gusdon AM, Qu S. Irisin: A new molecular marker and target in metabolic disorder. Lipids Health Dis. 2015; 14: 2.ChenJQHuangYYGusdonAMQuSIrisin: A new molecular marker and target in metabolic disorder201514210.1186/1476-511X-14-2441726425588692Search in Google Scholar
Taszarek A, Kaczmarkiewicz A, Miazgowski T. Nadciśnienie i inne choroby metaboliczne - czy krążąca iryzyna ma znaczenie? Nadciśnienie Tętnicze w Praktyce. 2016; 20: 5–10.TaszarekAKaczmarkiewiczAMiazgowskiTNadciśnienie i inne choroby metaboliczne - czy krążąca iryzyna ma znaczenie?201620510Search in Google Scholar
Vaughan RA, Gannon NP, Barberena MA, Garcia-Smith R, Bisoffi M, Mermier CM, Conn CA, Trujillo KA. Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab. 2014; 16: 711–718.VaughanRAGannonNPBarberenaMAGarcia-SmithRBisoffiMMermierCMConnCATrujilloKACharacterization of the metabolic effects of irisin on skeletal muscle in vitro20141671171810.1111/dom.1226824476050Search in Google Scholar
Huh JY, Dincer F, Mesfum E, Mantzoros CS. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int J Obes (Lond). 2014; 38: 1538–1544.HuhJYDincerFMesfumEMantzorosCSIrisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans2014381538154410.1038/ijo.2014.4224614098Search in Google Scholar
Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, Seufert J, Mantzoros CS. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017; 13: 324–337.PerakakisNTriantafyllouGAFernández-RealJMHuhJYParkKHSeufertJMantzorosCSPhysiology and role of irisin in glucose homeostasis20171332433710.1038/nrendo.2016.221587894228211512Search in Google Scholar
Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index. Peptides. 2013; 39: 125–130.StengelAHofmannTGoebel-StengelMElbeltUKobeltPKlappBFCirculating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index20133912513010.1016/j.peptides.2012.11.01423219488Search in Google Scholar
Crujeiras AB, Zulet MA, Lopez-Legarrea P, de la Iglesia R, Pardo M, Carreira MC, Martínez JA, Casanueva FF. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism. 2014; 63: 520–531.CrujeirasABZuletMALopez-LegarreaPde la IglesiaRPardoMCarreiraMCMartínezJACasanuevaFFAssociation between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients20146352053110.1016/j.metabol.2013.12.00724439241Search in Google Scholar
Ma J, Chen K. The role of Irisin in multiorgan protection. Mol Biol Rep. 2021; 48: 763–772.MaJChenKThe role of Irisin in multiorgan protection20214876377210.1007/s11033-020-06067-133389537Search in Google Scholar
Gannon NP, Vaughan RA, Garcia-Smith R, Bisoffi M, Trujillo KA. Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer. 2015; 136: E197–E202.GannonNPVaughanRAGarcia-SmithRBisoffiMTrujilloKAEffects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro2015136E197E20210.1002/ijc.2914225124080Search in Google Scholar
Kong G, Jiang Y, Sun X, Cao Z, Zhang G, Zhao Z, Zhao Y, Yu Q, Cheng G. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway. Oncol Rep. 2019; 38: 2647–2656.KongGJiangYSunXCaoZZhangGZhaoZZhaoYYuQChengGIrisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway2019382647265610.3892/or.2017.5973578001729048621Search in Google Scholar
Liu J, Song N, Huang Y, Chen Y. Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway. Sci Rep. 2018; 8: 15247.LiuJSongNHuangYChenYIrisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway201881524710.1038/s41598-018-33229-w618906130323244Search in Google Scholar
Shao L, Li H, Chen J, Song H, Zhang Y, Wu F, Wang W, Zhang W, Wang F, Li H, Tang D. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition. Biochem Biophys Res Commun. 2017; 485: 598–605.ShaoLLiHChenJSongHZhangYWuFWangWZhangWWangFLiHTangDIrisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition201748559860510.1016/j.bbrc.2016.12.08427986567Search in Google Scholar
Tekin S, Erden Y, Sandal S, Yilmaz B. Is irisin an anticarcinogenic peptide? Med Sci. 2015; 4: 2172–2180.TekinSErdenYSandalSYilmazBIs irisin an anticarcinogenic peptide?201542172218010.5455/medscience.2014.03.8210Search in Google Scholar
Zhang D, Zhang P, Li L, Tang N, Huang F, Kong X, Tan X, Shi G. Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathway. Onco Targets Ther. 2019; 12: 7243–7249.ZhangDZhangPLiLTangNHuangFKongXTanXShiGIrisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathway2019127243724910.2147/OTT.S214260673250731564907Search in Google Scholar
Shi G, Tang N, Qiu J, Zhang D, Huang F, Cheng Y, Ding K, Li W, Zhang P, Tan X. Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2017; 493: 585–591.ShiGTangNQiuJZhangDHuangFChengYDingKLiWZhangPTanXIrisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma201749358559110.1016/j.bbrc.2017.08.14828867187Search in Google Scholar
Moon HS, Mantzoros CS. Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines. Metabolism. 2014; 63: 188–193.MoonHSMantzorosCSRegulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines20146318819310.1016/j.metabol.2013.10.00524268368Search in Google Scholar
Kuloğlu T, Artaş G, Yardim M, Sahin I, Aydin Y, Beyoğlu N, Özercan İH, Yalcin MH, Ugur K, Aydin S. Immunostaining characteristics of irisin in benign and malignant renal cancers. Biotech Histochem. 2019; 94: 435–441.KuloğluTArtaşGYardimMSahinIAydinYBeyoğluNÖzercanİHYalcinMHUgurKAydinSImmunostaining characteristics of irisin in benign and malignant renal cancers20199443544110.1080/10520295.2019.158699830896263Search in Google Scholar
Ugur K, Aydin S, Kuloglu T, Artas G, Kocdor MA, Sahin İ, Yardim M, Ozercan İH. Comparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells. Cancer Manag Res. 2019; 11: 2595–2603.UgurKAydinSKulogluTArtasGKocdorMASahinİYardimMOzercanİHComparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells2019112595260310.2147/CMAR.S201979649789631114326Search in Google Scholar
Nowinska K, Jablonska K, Pawelczyk K, Piotrowska A, Partynska A, Gomulkiewicz A, Ciesielska U, Katnik E, Grzegrzolka J, Glatzel-Plucinska N, et al. Expression of irisin/FNDC5 in cancer cells and stromal fibroblasts of non-small cell lung cancer. Cancers. 2019; 11: 1538.NowinskaKJablonskaKPawelczykKPiotrowskaAPartynskaAGomulkiewiczACiesielskaUKatnikEGrzegrzolkaJGlatzel-PlucinskaNExpression of irisin/FNDC5 in cancer cells and stromal fibroblasts of non-small cell lung cancer201911153810.3390/cancers11101538682644231614634Search in Google Scholar
Provatopoulou X, Georgiou GP, Kalogera E, Kalles V, Matiatou MA, Papapanagiotou I, Sagkriotis A, Zografos GC, Gounaris A. Serum irisin levels are lower in patients with breast cancer: Association with disease diagnosis and tumor characteristics. BMC Cancer. 2015; 15: 898.ProvatopoulouXGeorgiouGPKalogeraEKallesVMatiatouMAPapapanagiotouISagkriotisAZografosGCGounarisASerum irisin levels are lower in patients with breast cancer: Association with disease diagnosis and tumor characteristics20151589810.1186/s12885-015-1898-1464263826560078Search in Google Scholar
El Khoury D, Maalouf GE. Exercise-induced irisin, the fat browning myokine, as a potential anticancer agent. J Obesity. 2019; 2019: 6561726.El KhouryDMaaloufGEExercise-induced irisin, the fat browning myokine, as a potential anticancer agent20192019656172610.1155/2019/6561726Search in Google Scholar
Zhang D, Tan X, Tang N, Huang F, Chen Z, Shi G. Review of research on the role of irisin in tumors. Onco Targets Ther. 2020; 13: 4423–4430.ZhangDTanXTangNHuangFChenZShiGReview of research on the role of irisin in tumors2020134423443010.2147/OTT.S245178724546432547073Search in Google Scholar
Krajowy Rejestr Nowotworów. http://onkologia.org.pl/nowotwory-zlosliwe-skory/ (16.09.2021)Krajowy Rejestr Nowotworówhttp://onkologia.org.pl/nowotwory-zlosliwe-skory/ (16.09.2021)Search in Google Scholar
Komorowska O, Szczerkowska-Dobosz A, Purzycka-Bohdan D, Rawicz-Zegrzda D, Dudziak M. Psoriasis as a risk factor of cardiovascular diseases. Przegl Dermatol. 2014; 101: 500–506.KomorowskaOSzczerkowska-DoboszAPurzycka-BohdanDRawicz-ZegrzdaDDudziakMPsoriasis as a risk factor of cardiovascular diseases201410150050610.5114/dr.2014.46953Search in Google Scholar
Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012; 26: 3–11.ReichKThe concept of psoriasis as a systemic inflammation: implications for disease management20122631110.1111/j.1468-3083.2011.04410.x22356630Search in Google Scholar
Baran A, Myśliwiec H, Kiluk P, Świderska M, Flisiak I. Serum irisin levels in patients with psoriasis. J Dermatolog Treat. 2017; 28: 304–308.BaranAMyśliwiecHKilukPŚwiderskaMFlisiakISerum irisin levels in patients with psoriasis20172830430810.1080/09546634.2016.125432727786588Search in Google Scholar
Menter A. Recognizing and managing comorbidities and complications in hidradenitis suppurativa. Semin Cutan Med Surg. 2014; 33 (3 Suppl): 54–56.MenterARecognizing and managing comorbidities and complications in hidradenitis suppurativa2014333 Suppl545610.12788/j.sder.009325188459Search in Google Scholar
Sadowska M, Lesiak A, Narbutt J. Choroby współistniejące z hidradenitis suppurativa. Forum Dermatologicum. 2019; 5: 112–116.SadowskaMLesiakANarbuttJChoroby współistniejące z hidradenitis suppurativa2019511211610.5603/FD.2019.0011Search in Google Scholar
Özkur E, Erdem Y, Altunay İK, Demir D, Dolu NÇ, Serin E, Cerman AA. Serum irisin level, insulin resistance, and lipid profiles in patients with hidradenitis suppurativa: A case-control study. An Bras Dermatol. 2020; 95: 708–713.ÖzkurEErdemYAltunayİKDemirDDoluNÇSerinECermanAASerum irisin level, insulin resistance, and lipid profiles in patients with hidradenitis suppurativa: A case-control study20209570871310.1016/j.abd.2020.04.009767240233008659Search in Google Scholar
Crujeiras AB, Pardo M, Arturo RR, Navas-Carretero S, Zulet MA, Martínez JA, Casanueva FF. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol. 2014; 26: 198–207.CrujeirasABPardoMArturoRRNavas-CarreteroSZuletMAMartínezJACasanuevaFFLongitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women20142619820710.1002/ajhb.2249324375850Search in Google Scholar
Mustafa AI, El-Shimi OS. Serum irisin: A prognostic marker for severe acne vulgaris. J Cosmet Dermatol. 2018; 17: 931–934MustafaAIEl-ShimiOSSerum irisin: A prognostic marker for severe acne vulgaris20181793193410.1111/jocd.1275330238599Search in Google Scholar
Álvarez-Villalobos NA, Rodríguez-Gutiérrez R, González-Saldivar G, Sánchez-García A, Gómez-Flores M, Quintanilla-Sánchez C, Treviño-Álvarez AM, Mancillas-Adame LG, González-González JG. Acanthosis nigricans in middle-age adults: A highly prevalent and specific clinical sign of insulin resistance. Int J Clin Pract. 2020; 74: e13453.Álvarez-VillalobosNARodríguez-GutiérrezRGonzález-SaldivarGSánchez-GarcíaAGómez-FloresMQuintanilla-SánchezCTreviño-ÁlvarezAMMancillas-AdameLGGonzález-GonzálezJGAcanthosis nigricans in middle-age adults: A highly prevalent and specific clinical sign of insulin resistance202074e1345310.1111/ijcp.1345331769902Search in Google Scholar
Chen JQ, Fang LJ, Song KX, Wang XC, Huang YY, Chai SY, Bu L, Qu S. Serum irisin level is higher and related with insulin in acanthosis nigricans-related obesity. Exp Clin Endocrinol Diabetes. 2016; 124: 203–207.ChenJQFangLJSongKXWangXCHuangYYChaiSYBuLQuSSerum irisin level is higher and related with insulin in acanthosis nigricans-related obesity201612420320710.1055/s-0035-156506026588491Search in Google Scholar